These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3755366)

  • 21. Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells.
    Ito H; Hidaka K; Miyata K; Kamato T; Nishida A; Honda K
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1127-32. PubMed ID: 1469624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of 5-hydroxytryptamine2 and 5-hydroxytryptamine3 receptors in rat dorsal root ganglion cells.
    Todorovic SM; Anderson EG
    J Pharmacol Exp Ther; 1990 Jul; 254(1):109-15. PubMed ID: 2366178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rabbit isolated renal artery contractions by some tryptamine derivatives, including 2-methyl-5-HT, are mediated by a 5-HT1-like receptor.
    Tadipatri S; Feniuk W; Saxena PR
    Br J Pharmacol; 1992 Oct; 107(2):322-8. PubMed ID: 1422584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of guinea-pig isolated iliac artery.
    Sahin-Erdemli I; Hoyer D; Stoll A; Seiler MP; Schoeffter P
    Br J Pharmacol; 1991 Feb; 102(2):386-90. PubMed ID: 1849768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual mechanism of the stimulant action of N,N-dimethyl-5-hydroxy-tryptamine (bufotenine) on cardiac sympathetic nerves.
    Fozard JR; Mobarok Ali AT
    Eur J Pharmacol; 1978 May; 49(1):25-30. PubMed ID: 658125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion.
    Ireland SJ; Jordan CC
    Br J Pharmacol; 1987 Oct; 92(2):417-27. PubMed ID: 3676602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of 5-HT3 receptor-mediated currents in dissociated frog sensory neurones by benzoxazine derivative, Y-25130.
    Yakushiji T; Akaike N
    Br J Pharmacol; 1992 Nov; 107(3):853-7. PubMed ID: 1472977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 5-HT3 receptor antagonists on 5-HT and nicotinic depolarizations in guinea-pig submucosal neurones.
    Vanner S; Surprenant A
    Br J Pharmacol; 1990 Apr; 99(4):840-4. PubMed ID: 2141798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of 5-hydroxytryptamine3 receptor-gated currents in adult rat dorsal root ganglion neurones.
    Robertson B; Bevan S
    Br J Pharmacol; 1991 Jan; 102(1):272-6. PubMed ID: 2043929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective antagonism of the GABA(A) receptor by ciprofloxacin and biphenylacetic acid.
    Green MA; Halliwell RF
    Br J Pharmacol; 1997 Oct; 122(3):584-90. PubMed ID: 9351519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic and electrophysiological effects of ICS 205-930, an antagonist of 5-hydroxytryptamine at peripheral receptors.
    Williams FM; Rothaul AL; Kane KA; Parratt JR
    J Cardiovasc Pharmacol; 1985; 7(3):550-5. PubMed ID: 2410689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism by propranolol of the ganglion stimulant action of 5-hydroxytryptamine.
    Weinstock M; Schechter Y
    Eur J Pharmacol; 1975; 32(02):293-301. PubMed ID: 238859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Hydroxytryptamine decreases the sensitivity of nicotinic acetylcholine receptor in bull-frog sympathetic ganglion cells.
    Akasu T; Koketsu K
    J Physiol; 1986 Nov; 380():93-109. PubMed ID: 3497266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for the presynaptic action of 5-hydroxytryptamine and the involvement of purinergic innervation in the rabbit lower urinary tract.
    Chen HI
    Br J Pharmacol; 1990 Sep; 101(1):212-6. PubMed ID: 2178017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of fast and slow depolarizations evoked by 5-HT in guinea-pig coeliac ganglion cells in vitro.
    Wallis DI; Dun NJ
    Br J Pharmacol; 1988 Jan; 93(1):110-20. PubMed ID: 3349227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Origin of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion and vagus nerve.
    Ireland SJ
    Br J Pharmacol; 1987 Oct; 92(2):407-16. PubMed ID: 3676601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of 5-hydroxytryptamine uptake on the apparent 5-hydroxytryptamine antagonist potency of metoclopramide in the rat isolated superior cervical ganglion.
    Ireland SJ; Straughan DW; Tyers MB
    Br J Pharmacol; 1987 Jan; 90(1):151-60. PubMed ID: 3814917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
    Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
    Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.